Sign up to save your podcasts
Or
Share Regeneron to Acquire 23andMe for $256M
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Regeneron to Acquire 23andMe for $256M
Regeneron Pharmaceuticals has agreed to acquire 23andMe’s consumer genetics business and assets for $256 million, following 23andMe’s Chapter 11 bankruptcy.
View all episodes
By Regeneron Pharmaceuticals has agreed to acquire 23andMe’s consumer genetics business and assets for $256 million, following 23andMe’s Chapter 11 bankruptcy.